期刊文献+

1例2-甲基3-羟基丁酰辅酶A脱氢酶缺陷症患儿的临床诊治 被引量:2

Clinical diagnosis and treatment of 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in one infant:a case report
下载PDF
导出
摘要 目的:通过对1例2-甲基3-羟基丁酰辅酶A脱氢酶缺陷症患儿的临床表现及检查结果的分析,提高对此类疾病的认识,为该病的及时诊断和治疗提供依据。方法:采用回顾性方法对我院收治的这名患儿的临床症状和体征、实验室常规检查结果、血、尿串联质谱和气相质谱检查结果、X光胸片、彩超、头颅MR、脑电图以及诊疗情况进行回顾和分析。结果:患儿3岁,主要临床表现初期以腹泻、呕吐为主,后来出现嗜睡、意识障碍,气促、难以纠正的代谢性酸中毒等。头颅MRI显示双侧侧脑室轻度扩张,脑沟、脑裂稍增宽。脑电图检查结果为界线性幼儿期脑电图,额、中央区尖波数次发放。血串联质谱检查天冬氨酸等氨基酸升高,尿气相质谱2-甲基-3-羟基丁酸明显增高,但未发现甲基巴豆酰甘氨酸和2-甲基乙酰已酸的异常,基因检测结果为hadh2基因第4外显子p.R130C突变。结论:2-甲基3-羟基丁酰辅酶A脱氢酶缺陷症极为罕见,对有不明原因的难于纠正的代谢性酸中毒、高氨血症、或不明原因的精神萎靡、意识障碍等神经系统症状患儿应警惕该病,可送血或尿标本进行串联质谱、气相质谱及基因分析,以便早期诊断及治疗。 Objective:To The clinical manifestations and examination results of one infant with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency(MHBDD)was reviewed to enhance the understanding,diagnosis and treatment of MHBD.Methods:The clinical manifestations and results of laboratory tests,tandem mass spectrometry of the blood sample,gas chromatography-mass spectrometry of the urine sample,chest X-ray,color Doppler examination,brain MRI and EEG as well as the treatment of this case were analyzed retrospectively.Results:This infant,aged 3 years old,mainly presented the symptoms of diarrhea and vomiting initially,and later lethargy,disturbance of consciousness,dyspnea and incorrigible metabolic acidosis.Brain MRI indicated mild ventriculomegaly and widening of sulci bilaterally.Borderline EEG was observed,with several sharp wave discharges in the frontal and central regions of the brain.Tandem mass spectrometry of the blood sample indicated increased levels of aspartic acid and other amino acids;gas chromatography of the urine sample indicated an obvious increase of 2-methyl-3-hydroxybutyric acid,but the levels of3-methylcrotonyl-glycine or 2-methyl-acetoacetic acid were basically normally.Gene detection revealed p.R130 C mutation in exon 4 of the hadh2 gene.Conclusion:As a rare disease,MHBDD may be suspected for infants presenting with incorrigible metabolic acidosis and hyperammonemia or neurological symptoms such as lethargy and disturbance of consciousness for unknown reasons.Examination techniques including tandem mass spectrometry,gas chromatography-mass spectrometry of the blood and urine samples and gene detections can be used for early diagnosis and treatment.
作者 李莹莹 崔亚利 王霞 戴维 蒋冬梅 张晓东 王泓 Li Ying-ying;CuiYa-li;Wang Xia;Dai Wei;Jiang Dong-mei;Zhang Xiao-dong;Wang Hong(Department of Laboratory Medicine, West China Second University Hospital, Sichuan University;Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Sichuan Chengdu 610041)
出处 《四川生理科学杂志》 2017年第4期183-186,共4页 Sichuan Journal of Physiological Sciences
基金 四川大学横向课题(编号:15H0912)
关键词 遗传代谢病 2-甲基3-羟基丁酰辅酶A脱氢酶缺陷症 串联质谱技术 气相质谱技术 Inherited metabolic disease 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency Tandem mass spectrometry Gas chromatography-mass spectrometry
  • 相关文献

参考文献1

二级参考文献14

  • 1Zschocke J, Ruiter JP, Brand J, et al. Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: a novel inborn error of branched-chain fatty acid and isoleucine metabolism. Pediatr Res,2000,48:852-855.
  • 2Korman SH. Inborn errors of isoleucine degradation: a review. Mol Genet Metab,2006 ,89 :289-299.
  • 3Ensenauer R, Niederhoff H, Ruiter JP, et al. Clinical variability in 3-hydroxy-2- methylbutyryl-CoA dehydrogenase deficiency. Ann Neuro1,2002 ,51:656-659.
  • 4Olpin SE, Pollitt RJ, McMenamin J, et al. 2-Methyl-3- hydroxybutyryl-CoA dehydrogenase deficiency in a 23 year old man. J Inherit Metab Dis,2002,25:477-482.
  • 5Sutton VR, OBrien WE, Clark GD, et al. 3-Hydroxy-2- methylbutyryl-CoA dehydrogenase deficiency. J Inherit Metab Dis ,2003,26:69-71.
  • 6Poll-The BT, Wanders R J, Ruiter JP, et al. Spastic diplegia and periventricular white matterabnormalities in 2-methyl-3 - hydroxybutyryl-CoA dehydrogenase deficiency, a defect of isoleucine metabolism : differential diagnosis with hypoxic- ischemic brain diseases. Mol Genet Metab,2004,81:295-299.
  • 7Sass JO, Forstner R, Sped W. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: impaired catabolism of isoleucine presenting as neurodegenerative disease. Brain Dev ,2004,26 : 12-14.
  • 8Perez-Cerda C, Garcia-Villoria J, Ofman R, et al. 2-Methyl-3- hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: an X- linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease. Pediatr Res,2005 ,58 :488-491.
  • 9Cazorla MR, Verd6 A, P6rez-Cerd6 C, et al. Neuroimage findings in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency. Pediatr Neurol,2007 ,36 :264-267.
  • 10Garcfa-Villoria J, Navarro-Sastre A, Fons C, et al. Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: difficuhiesin the diagnosis. Clin Biochem .2009.42.27-33.

共引文献7

同被引文献4

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部